INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

VRXAVeraxa Biotech AG - Post de-SPAC

CIK 0002079109

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells5 / 0
Max Insider Score46
Connections5with evidence

VRXA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
46
GM
Gruninger MarcDirector
VRXAVeraxa Biotech AG - Post de-SPAC
Open-market purchase
BUY$850
867 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Gruninger MarcDirector · Oct 29, 2026
  • ← Insider ofevidence
    Ziegler Christoph SamuelDirector · Oct 21, 2026
  • ← Insider ofevidence
    Baumann Oliver RolfDirector · Aug 31, 2026
42
GM
Gruninger MarcDirector
VRXAVeraxa Biotech AG - Post de-SPAC
Open-market purchase
BUY
$9,133
9,133 sh
Oct 28, 2026
Oct 29, 2026
traded Oct 28, 2026
+1d
SEC FORM 4

Evidence

46
ZS
Ziegler Christoph SamuelDirector
VRXAVeraxa Biotech AG - Post de-SPAC
Open-market purchase
BUY$33K
30.0K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC FORM 4

Evidence

37
BR
Baumann Oliver RolfDirector
VRXAVeraxa Biotech AG - Post de-SPAC
Open-market purchase
BUY$75K
50.0K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

46
AR
Antz Christoph RudigerDirector, Chief Executive Officer
VRXAVeraxa Biotech AG - Post de-SPAC
Open-market purchase
BUY$7,650
5,000 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

← Insider ofevidence
Antz Christoph Rudiger
Director, Chief Executive Officer · Aug 31, 2026